BACTOCILL Drug Patent Profile
✉ Email this page to a colleague
When do Bactocill patents expire, and when can generic versions of Bactocill launch?
Bactocill is a drug marketed by Glaxosmithkline and Baxter Hlthcare and is included in six NDAs.
The generic ingredient in BACTOCILL is oxacillin sodium. There are thirty-eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the oxacillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bactocill
A generic version of BACTOCILL was approved as oxacillin sodium by SAGENT PHARMS on March 30th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BACTOCILL?
- What are the global sales for BACTOCILL?
- What is Average Wholesale Price for BACTOCILL?
Summary for BACTOCILL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 88 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,835 |
| DailyMed Link: | BACTOCILL at DailyMed |
Recent Clinical Trials for BACTOCILL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cubist Pharmaceuticals LLC | Phase 2 |
US Patents and Regulatory Information for BACTOCILL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | BACTOCILL | oxacillin sodium | CAPSULE;ORAL | 061336-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Glaxosmithkline | BACTOCILL | oxacillin sodium | INJECTABLE;INJECTION | 062736-001 | Dec 19, 1986 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Glaxosmithkline | BACTOCILL | oxacillin sodium | CAPSULE;ORAL | 062241-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
